Akash Bakshi serves as Executive at NeuroBo Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Akash Bakshi has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 31, 2020 involved receiving (via award) 855,059 shares valued at $0.
Akash Bakshi currently holds 884,072 shares of NeuroBo Pharmaceuticals, Inc. (NRBO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Akash Bakshi has been a net neutral trader of NRBO stock. They have purchased $0 and sold $0 worth of shares.
Akash Bakshi's most recent insider trade was on Dec 31, 2020, when they sold 855,059 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |